Dr. Fangusaro joined Children’s as Director of Developmental Therapeutics in 2018. He came to Georgia by way of Northwestern Feinberg School of Medicine and Lurie Children’s Hospital of Chicago, where he was Director of the Pediatric Neuro-oncology Program. He has an expertise and specialty training in treating children with central nervous system malignancies, including brain and spinal cord tumors.
Dr. Fangusaro is humbled and honored to be working alongside the amazing developmental therapeutics and neuro-oncology teams at Children’s and Emory. He looks forward to continued growth on the regional, national and international level. He truly feels lucky to work with such an amazing population of patients and families who inspire him every single day.
Dr. Fangusaro’s primary area of research is the development of early phase clinical trials, novel therapeutics and relevant biologic correlates in an effort to improve survival outcomes and minimize toxicities. Within pediatric brain tumors, his research has focused on three main areas: low-grade gliomas, central nervous system germ cell tumors and early phase clinical trials. Dr. Fangusaro partners with the pharmaceutical industry on investigator-initiated trials and serves as the principal investigator on numerous national trials.
- Member, Children's Oncology Group (COG) Brain Tumor Steering Committee
- Vice chair, Pediatric Brain Tumor Consortium (PBTC)
Focus of Practice
- Central nervous system malignancies, including brain and spinal cord tumors
- Developmental therapeutic and early phase clinical trials for patients with brain and spinal cord tumors